Clinical Trial Update: Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of tacrolimus formulation on neurological side effects in older kidney transplant recipients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of California, Davis | Conditions: Kidney Transplant; Complications, Toxicity | Phase 4 | Status: COMPLETED | Results posted: 2025-04-08